Clinuvel Pharmaceuticals (CLVLY)

[ghmm]

Considering the shares outstanding the volume while much higher then normal is still relatively modest. I know a large number of shares are closely held but they're obviously not selling in an significant amounts the past few days.

I don't doubt he (or something else) is causing a share price increase after frankly a very bad quarterly result. Still if the company manages to submit (and get the file accepted) the stock could be in line for a major move on potential FDA approval. To me its more riskier the company properly completes the file and is accepted. They should get priority review and then we're looking at a Q3 potential approval. Even if they aren't ready to launch (which unfortunately I think mangement likely won't be) the stock should be significantly higher. Lets just hope they stop the uniform pricing nonsense for the US.

I really wish they would have some experienced/competent people moving it forward if not its probably more value creation if someone comes and buys us out who knows what they're doing in rare diseases.